CAN ONABOTULINUMTOXINA IMPROVE SYMPTOMS AND QUALITY OF LIFE IN ALL PATIENTS WITH OVERACTIVE BLADDER, REGARDLESS OF DISEASE DURATION OR BODY MASS INDEX?

被引：0
|
作者：
Chermansky, C. [1 ]
Rechberger, T. [2 ]
Miles-Thomas, J. [3 ]
Hale, D. [4 ]
Cardozo, L. [5 ]
Orejudos, A. [6 ]
Patel, A. [7 ]
Herschorn, S. [8 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Med Univ Lublin, Lublin, Poland
[3] Urol Virginia, Virginia Beach, VA USA
[4] Urogynecol Associates Pc, Indianapolis, IN USA
[5] Kings Coll Hosp London, London, England
[6] Allergan Plc, Irvine, CA USA
[7] Allergan Plc, Marlow, Bucks, England
[8] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
关键词：
PLACEBO-CONTROLLED TRIAL; URINARY-INCONTINENCE; DOUBLE-BLIND;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
270
引用
收藏
页码：S219 / S220
页数：2
相关论文
共 50 条
  • [21] LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE FOLLOWING ONABOTULINUMTOXINA TREATMENT IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE
    Sand, P. K.
    Khullar, V.
    Joshi, M.
    Zheng, Y.
    Nitti, V.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S61 - S62
  • [22] Impact of body mass index and gender on quality of life in patients with gastroesophageal reflux disease
    Lee, Shou-Wu
    Lien, Han-Chung
    Chang, Chi-Sen
    Peng, Yen-Chun
    Ko, Chung-Wang
    Chou, Ming-Chih
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (36) : 5090 - 5095
  • [23] Influence of Body Mass Index on Quality of Life and Disease Activity in Crohn's Patients
    Issa, Mazen
    Ananthakrishnan, Ashwin
    Zadvornova, Yelena
    Naik, Amar
    Stein, Daniel
    Perera, Lilani
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S477 - S477
  • [24] Impact of body mass index and gender on quality of life in patients with gastroesophageal reflux disease
    Shou-Wu Lee
    Han-Chung Lien
    Chi-Sen Chang
    Yen-Chun Peng
    Chung-Wang Ko
    Ming-Chih Chou
    World Journal of Gastroenterology, 2012, (36) : 5090 - 5095
  • [25] LOW INCIDENCE OF CLEAN INTERMITTENT CATHETERISATION WITH ONABOTULINUMTOXINA IN DIVERSE AGE GROUPS OF OVERACTIVE BLADDER PATIENTS WITH CORRESPONDING IMPROVEMENTS IN URINARY SYMPTOMS, TREATMENT RESPONSE, AND QUALITY OF LIFE
    Nitti, V
    Drake, M.
    Everaert, K.
    Rovner, E.
    Dmochowski, R.
    Ginsberg, D.
    Radomski, S.
    Aboushwareb, T.
    Chang, C.
    Chapple, C.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S300 - S301
  • [26] Correlation Between Overactive Bladder Symptoms and Quality of Life in Japanese Male Patients: Focus on Nocturia
    Takao, Tetsuya
    Tsujimura, Akira
    Kiuchi, Hiroshi
    Takezawa, Kentaro
    Okuda, Hidenobu
    Yamamoto, Keisuke
    Fukuhara, Shinichiro
    Miyagawa, Yasushi
    Nonomura, Norio
    UROLOGY, 2013, 82 (01) : 189 - 193
  • [27] IXEKIZUMAB IMPROVES THE SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS REGARDLESS OF SEX, DURATION OF DISEASE, OR BODY MASS INDEX IN TWO RANDOMIZED, PHASE 3 CLINICAL TRIALS
    Eder, Lihi
    Odhav, Satish
    Korkosz, Mariusz
    Sprabery, Aubrey Trevelin
    Gellett, Amanda M.
    Lin, Chen-Yen
    Park, So Young
    Bertram, Clinton C.
    Ogdie, Alexis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 904 - 905
  • [28] TREATMENT WITH ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES EPISODES OF URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME
    Sand, Peter
    Parsons, Matthew
    Zhou, Jihao
    Globe, Denise
    Nardo, Christopher
    Khullar, Vik
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 209 - 209
  • [29] Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder
    Ginsberg, David A.
    Drake, Marcus J.
    Kaufmann, Albert
    Radomski, Sidney
    Gousse, Angelo E.
    Chermansky, Christopher J.
    Magyar, Andrew
    Nicandro, Jean Paul
    Nitti, Victor W.
    JOURNAL OF UROLOGY, 2017, 198 (04): : 898 - 905
  • [30] EARLY AND CONSISTENT IMPROVEMENTS IN URINARY SYMPTOMS AND QUALITY OF LIFE WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL
    McCammon, Kurt
    Gousse, Angelo
    Gruenenfelder, Jennifer
    Hale, Douglass
    Orejudos, Amelia
    Aboushwareb, Tamer
    Patel, Anand
    Kohan, Alfred
    TOXICON, 2018, 156 : S79 - S79
12345